SCHEMBL308555

SCHEMBL308555

CCCCCCCCOC(=O)c1ccccc1OC(=O)c1ccccc1OCC(CC)CCCC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 1/20 0.60
PRSS2 P07478 1/20 0.60
PRSS3 P35030 1/20 0.60
ALDH1A1 P00352 9/20 0.59
CYP3A4 P08684 4/20 0.59
CA2 P00918 1/20 0.59
TSHR P16473 6/20 0.55
LMNA P02545 5/20 0.55
MAPK1 P28482 4/20 0.53
TP53 P04637 1/20 0.53
KDM4E B2RXH2 4/20 0.50
HSD17B10 Q99714 2/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 2/20 0.48
MEN1 O00255 1/20 0.48
NR1I2 O75469 1/20 0.48
CHRM2 P08172 1/20 0.48
ADRA2A P08913 1/20 0.48
OPRK1 P41145 1/20 0.48
HTR2B P41595 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL322471 0.92 PRSS1 (0.68) PRSS1PRSS2PRSS3ALDH1A1CYP3A4
SCHEMBL4167259 0.88 PRSS1 (0.74) PRSS1PRSS2PRSS3ALDH1A1CYP3A4
SCHEMBL5918234 0.86 ALDH1A1 (0.80) PRSS1PRSS2PRSS3ALDH1A1CYP3A4
SCHEMBL5670019 0.85 LMNA (0.65) PRSS1PRSS2PRSS3ALDH1A1CYP3A4
SCHEMBL29500373 0.85 LMNA (0.65) PRSS1PRSS2PRSS3ALDH1A1CYP3A4
SCHEMBL28685174 0.85 ALDH1A1 (0.69) PRSS1PRSS2PRSS3ALDH1A1CYP3A4
Bis(2-Ethylhexyl) Phthalate SCHEMBL9473452 0.84 PRSS1 (0.85) PRSS1PRSS2PRSS3ALDH1A1CYP3A4
Bis(2-Ethylhexyl) Phthalate SCHEMBL8498138 0.84 PRSS1 (0.85) PRSS1PRSS2PRSS3ALDH1A1CYP3A4
Bis(2-Ethylhexyl) Phthalate SCHEMBL6245567 0.84 PRSS1 (0.85) PRSS1PRSS2PRSS3ALDH1A1CYP3A4
SCHEMBL2351535 0.84 PRSS1 (0.85) PRSS1PRSS2PRSS3ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8092787-B2 mixture of benefication compound and crystal material; separately prepared them mixed UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) 2012-01-10 US disclosed
EP-1479365-B1 Personal product composition comprising a structured benefit agent composition and a delivery vehicle UNILEVER PLC (GB) 2011-08-31 EP disclosed
US-7875582-B2 hydrophobic moisturizing oils UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) 2011-01-25 US disclosed
EP-1032405-A4 ANTIMUTAGENIC COMPOSITIONS FOR TREATMENT AND PREVENTION OF PHOTODAMAGE TO SKIN WELLSTAT THERAPEUTICS CORP (US) 2007-05-02 EP disclosed
US-RE39573-E1 Antimutagenic compositions for treatment and prevention of photodamage to skin WELLSTAT THERAPEUTICS CORPORATION (US) 2007-04-17 US disclosed
US-20060128580-A1 PROCESS FOR MAKING BAR COMPOSITION HAVING LITTLE OR NO EFFLORESCENCE UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2006-06-15 US disclosed
US-6465440-B2 ADMINISTERING TO SKIN A COMPOSITION CONTAINING DEOXYRIBONUCLEOSIDES IN CONCENTRATIONS SUFFICIENT TO ENHANCE DNA REPAIR OR REDUCE MUTATION FREQUENCY IN A VEHICLE CAPABLE OF DELIVERING DEOXYRIBONUCLEOSIDES TO SKIN CELLS WELLSTAT THERAPEUTICS CORPORATION 2002-10-15 US disclosed
US-6417170-B2 ADMINISTERING TO SKIN A COMPOSITION CONTAINING DEOXYRIBONUCLEOSIDES IN CONCENTRATIONS SUFFICIENT TO ENHANCE DNA REPAIR OR REDUCE MUTATION FREQUENCY IN A VEHICLE CAPABLE OF DELIVERING DEOXYRIBONUCLEOSIDES TO SKIN CELLS PRO-NEURON, INC. 2002-07-09 US disclosed
US-6403565-B1 ENHANCES DNA REPAIR AND PREVENTS CONSEQUENCES OF MUTAGENIC RADIATION EVEN WHEN ADMINISTERED AFTER DAMAGE OR EXPOSURE TO RADIATION HAS ALREADY OCCURRED; DEOXYRIBONUCLEOSIDES: DEOXYCYTIDINE, DEOXYADENOSINE, DEOXYGUANOSINE, AND THYMIDINE. PRO-NEURON, INC. 2002-06-11 US disclosed
US-20020006913-A1 ANTIMUTAGENIC COMPOSITIONS FOR TREATMENT AND PREVENTION OF PHOTODAMAGE TO SKIN PRO-NEURON, INC. 2002-01-17 US disclosed
US-20010044421-A1 Administering to skin a composition containing deoxyribonucleosides in concentrations sufficient to enhance DNA repair or reduce mutation frequency in a vehicle capable of delivering deoxyribonucleosides to skin cells PRO-NEURON, INC. 2001-11-22 US disclosed
US-20010044419-A1 Antimutagenic compositions for treatment and prevention of photodamage to skin PRO-NEURON, INC. 2001-11-22 US disclosed
US-6255290-B1 REDUCING SENSITIVITY TO SKIN CANCER; TOPICAL ADMINISTERING OF NUCLEOTIDE PRO-NEURON, INC. 2001-07-03 US disclosed
EP-1032405-A1 ANTIMUTAGENIC COMPOSITIONS FOR TREATMENT AND PREVENTION OF PHOTODAMAGE TO SKIN PRO-NEURON, INC. (US) 2000-09-06 EP disclosed
WO-1999022741-A1 ANTIMUTAGENIC COMPOSITIONS FOR TREATMENT AND PREVENTION OF PHOTODAMAGE TO SKIN PRO-NEURON, INC. (US) 1999-05-14 WO disclosed